EUVIMEDOpdag EUVIMED
Crossref

Discovery of Small Molecule PD ‐ L1 Inhibitors via Optimization of Solvent‐Interaction Region for Cancer Immunotherapy

Binbin Cheng, Ting Liu, Hao Cao, Jin Liu, Yichang Ren, Junli Huang, Dulin Kong, Ting Chen, Yong Liu, Jianjun Chen iD

Chemical Biology & Drug Design · 2025-06 · 105 (6)

DOI: 10.1111/cbdd.70141 ↗

At a glance

Journal article in Chemical Biology & Drug Design, published online on 2025-06-09. Written by Binbin Cheng and 9 co-authors. Institution: School of Medicine, Hubei Polytechnic University, Huangshi, China. Major MEDLINE topics: B7-H1 Antigen, Small Molecule Libraries, Immunotherapy, Immune Checkpoint Inhibitors. Cited 2 times so far (Crossref); 16 references. Funded by: the scientific research project of high-level talents in Southern Medical University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Despite extensive research, the topic of anti‐PD‐L1 small‐molecule inhibitors remains elusive. Herein, we report the design, synthesis, and bioevaluation of a series of small molecule PD‐L1 inhibitors via optimization of the solvent‐interaction region. Among them, compound GJ19 showed the most potent anti‐PD‐L1 effects with an IC 50 of 32.06 nM in the HTRF (homogenous time‐resolved fluorescence) assay, better than BMS‐202 (IC 50 = 62.1 nM). In addition, the SPR (surface plasmon resonance) assay revealed that GJ19 can effectively bind to human/murine PD‐L1 protein with K D values of 171 and 290 nM, respectively. Furthermore, GJ19 concentration‐dependently promoted HepG2 cell mortality in a co‐culture model of HepG2/hPD‐L1 and Jurkat T/hPD‐1 cells. In the in vivo efficacy studies, GJ19 (intraperitoneal injection, 15 mg/kg) effectively suppressed tumor growth with a TGI of 56.8% in a B16‐F10 melanoma mouse model by activating antitumor immunity. In conclusion, GJ19 represents a potential small molecule inhibitor of PD‐L1, deserving further investigation for tumor immunotherapy.

Subjects

MeSH terms (MEDLINE)

B7-H1 AntigenSmall Molecule LibrariesImmunotherapyImmune Checkpoint InhibitorsAntineoplastic AgentsHumansAnimalsMiceHep G2 CellsSolventsJurkat CellsMice, Inbred C57BLMolecular Docking SimulationCell Proliferation

Author keywords

cancer immunotherapysmall molecule PD‐L1 inhibitorsolvent‐interaction region

Substances

B7-H1 AntigenSmall Molecule LibrariesCD274 protein, humanSolventsImmune Checkpoint InhibitorsAntineoplastic Agents

Authors and institutions

  • School of Medicine, Hubei Polytechnic University, Huangshi, China.
  • School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou, China.
  • Longhua District People's Hospital of Shenzhen, Shenzhen, China.
  • Department of Medicine, People's Hospital of Xiangzhou District, Zhuhai, Guangdong, P. R. China.
  • Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, International Joint Research Center of Human-Machine Intelligent Collaborative for Tumor Precision Diagnosis and T…
  • Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

ORCID profiles: Jianjun Chen

Funding

  • the scientific research project of high-level talents in Southern Medical University

Cite

APA

Cheng, B., Liu, T., Cao, H., Liu, J., Ren, Y., Huang, J., Kong, D., Chen, T., Liu, Y., & Chen, J. (2025). Discovery of Small Molecule PD ‐ L1 Inhibitors via Optimization of Solvent‐Interaction Region for Cancer Immunotherapy. Chemical Biology & Drug Design, 105(6). https://doi.org/10.1111/cbdd.70141

Vancouver

Cheng B, Liu T, Cao H, Liu J, Ren Y, Huang J, et al. Discovery of Small Molecule PD ‐ L1 Inhibitors via Optimization of Solvent‐Interaction Region for Cancer Immunotherapy. Chemical Biology & Drug Design. 2025;105(6). doi:10.1111/cbdd.70141

BibTeX
@article{Cheng2025,
  author = {Cheng, Binbin and Liu, Ting and Cao, Hao and Liu, Jin and Ren, Yichang and Huang, Junli and Kong, Dulin and Chen, Ting and Liu, Yong and Chen, Jianjun},
  title = {Discovery of Small Molecule PD ‐ L1 Inhibitors via Optimization of Solvent‐Interaction Region for Cancer Immunotherapy},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  volume = {105},
  number = {6},
  doi = {10.1111/cbdd.70141}
}
Start for free →